PDL BioPharma

PDL BioPharma Provides Second Quarter 2013 Royalty Revenue Guidance of $143 Million
PDL BioPharma Provides Second Quarter 2013 Royalty Revenue Guidance of $143 Million
PDL BioPharma , Inc. PDLI Q3 2011 Earnings Call Transcript
Good afternoon and welcome to PDL BioPharma's third quarter 2011 earnings conference call. Today's call is being recorded.
Elan Issues Response Document Further Detailing Inadequacy of Royalty Pharma's Revised Offer
Elan Issues Response Document Further Detailing Inadequacy of Royalty Pharma's Revised Offer

Our Products

Tools

Resources

Services

Upcoming Events

Conferences

Morningstar Investment Conference
June 12-14, 2013
Chicago, IL
Conference hashtag: #MIC25
Morningstar ETF Invest Conference
Oct. 2-4, 2013
Chicago, IL
Conference hashtag: #ETFInvest

Webinars

Real Assets to the Rescue
Tuesday, April 9
11:00 a.m. ET | 10:00 a.m. CT
The Hunt for Income
Tuesday, January 29
11:00 a.m. ET | 10:00 a.m. CT
Introduction to ETF Managed Portfolios
Monday, December 10
4:00 p.m. ET | 3:00 p.m. CT
Using ETFs for Income
Aired on Tuesday, June 12
Archive